###begin article-title 0
A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage
###end article-title 0
###begin p 1
###xml 95 121 95 121 <email xmlns:xlink="http://www.w3.org/1999/xlink">k.w.caldecott@sussex.ac.uk</email>
To whom correspondence should be addressed. Tel: +44 1273 877519; Fax: +44 1273 678121; Email: k.w.caldecott@sussex.ac.uk
###end p 1
###begin p 2
###xml 25 31 <span type="species:ncbi:8164">Suzuki</span>
Present address: Hiroshi Suzuki, National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Nishi 2-13, Inada-cho, Obihiro, Hokkaido 080-8555, Japan
###end p 2
###begin p 3
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 327 328 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 787 793 787 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adprt1</italic>
###xml 793 796 793 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 793 796 793 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 824 825 824 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 826 827 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The molecular role of poly (ADP-ribose) polymerase-1 in DNA repair is unclear. Here, we show that the single-strand break repair protein XRCC1 is rapidly assembled into discrete nuclear foci after oxidative DNA damage at sites of poly (ADP-ribose) synthesis. Poly (ADP-ribose) synthesis peaks during a 10 min treatment with H2O2 and the appearance of XRCC1 foci peaks shortly afterwards. Both sites of poly (ADP-ribose) and XRCC1 foci decrease to background levels during subsequent incubation in drug-free medium, consistent with the rapidity of the single-strand break repair process. The formation of XRCC1 foci at sites of poly (ADP-ribose) was greatly reduced by mutation of the XRCC1 BRCT I domain that physically interacts with PARP-1. Moreover, we failed to detect XRCC1 foci in Adprt1-/- MEFs after treatment with H2O2. These data demonstrate that PARP-1 is required for the assembly or stability of XRCC1 nuclear foci after oxidative DNA damage and suggest that the formation of these foci is mediated via interaction with poly (ADP-ribose). These results support a model in which the rapid activation of PARP-1 at sites of DNA strand breakage facilitates DNA repair by recruiting the molecular scaffold protein, XRCC1.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c1">1</xref>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c2">2</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c3">3</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c7">7</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c8">8</xref>
Single-strand breaks (SSBs) can arise directly (e.g. by fragmentation of damaged deoxyribose) or indirectly (e.g. during the enzymatic excision of abasic sites) (1,2). The importance of repairing SSBs is suggested by the increased spontaneous and/or induced genetic instability of cell lines in which polypeptide components of this process are absent or mutated (3-7). It is likely that, if not repaired, SSBs are converted into DSBs during DNA replication (8).
###end p 5
###begin p 6
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c9">9</xref>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xrcc1</italic>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c10">10</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c2">2</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c11">11</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c12">12</xref>
###xml 532 534 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c13">13</xref>
###xml 535 537 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c14">14</xref>
###xml 566 568 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c11">11</xref>
###xml 596 598 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c15">15</xref>
###xml 599 601 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c18">18</xref>
###xml 684 686 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c13">13</xref>
###xml 687 689 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c19">19</xref>
###xml 261 265 <span type="species:ncbi:10090">Mice</span>
A critical component of SSBR is the polypeptide XRCC1. Mutant cell lines lacking XRCC1 display hypersensitivity to a broad range of genotoxins, increased frequencies of translocations and deletions, and a reduced ability to rapidly repair chromosomal SSBs (9). Mice with targeted disruption of both Xrcc1 alleles exhibit early embryonic lethality (10). At the molecular level, XRCC1 appears to coordinate or stimulate enzymatic components of SSBR by physical interaction (2,11). XRCC1 interacts with APE1 (12), DNA polymerase beta (13,14), DNA polynucleotide kinase(11), and DNA ligase IIIalpha (15-18). In addition, XRCC1 also interacts with poly (ADP-ribose) polymerase-1 (PARP-1) (13,19).
###end p 6
###begin p 7
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c20">20</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c21">21</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c19">19</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c22">22</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c23">23</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c24">24</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
PARP-1 rapidly binds to DNA strand breaks (SSBs) and is thereby activated, covalently automodifying itself and, to a lesser extent, proximal acceptor proteins with poly (ADP-ribose) polymer (PAR) (20,21). XRCC1 preferentially interacts with automodified PARP-1, most likely via a PAR-binding motif present within the internal BRCT I domain of XRCC1 (19,22). Consistent with this, inhibiting PAR synthesis with 3-aminobenzamide greatly reduces or ablates the interaction of XRCC1 with PARP-1 (23,24). These data have prompted the hypothesis that one function of PARP-1 is to recruit XRCC1 to sites of SSBs. In agreement with this, the XRCC1 BRCT I domain is critical for SSBR and for cell survival mediated by XRCC1 after DNA alkylation (25). However, evidence that PARP-1 might recruit XRCC1 to SSBs is currently lacking.
###end p 7
###begin p 8
###xml 174 175 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 193 194 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 559 560 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 561 562 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 618 624 618 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adprt1</italic>
###xml 639 645 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1</italic>
###xml 566 571 <span type="species:ncbi:10090">mouse</span>
Here, we have addressed the spatial and temporal relationship between PAR synthesis and the assembly of XRCC1 subnuclear foci during the repair of oxidative SSBs induced by H2O2. We show that H2O2 induces the rapid and transient formation of PAR nuclear foci, indicative of the binding and activation of PARP-1 at DNA strand breaks, followed soon after by the appearance of XRCC1 nuclear foci at the same sites. Mutation of the XRCC1 BRCT I domain that interacts with PAR reduces or prevents the appearance of XRCC1 foci, and XRCC1 foci fail to appear after H2O2 in mouse cells harbouring a targeted disruption of the Adprt1 gene encoding Parp-1. These data provide evidence that PARP-1 is required for the recruitment of XRCC1 to sites of chromosomal DNA strand breakage.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Cells and cell culture
###end title 10
###begin p 11
###xml 188 193 184 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 203 210 199 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 435 440 431 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 451 458 447 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 495 500 491 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R399Q</sup>
###xml 508 513 504 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W385D</sup>
###xml 521 532 517 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LI360/361DD</sup>
###xml 639 641 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
###xml 671 677 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adprt1</italic>
###xml 677 680 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 677 680 673 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 685 691 681 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adprt1</italic>
###xml 691 694 687 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 691 694 687 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 724 726 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c26">26</xref>
###xml 111 115 <span type="species:ncbi:9913">calf</span>
###xml 695 700 <span type="species:ncbi:10090">mouse</span>
###xml 800 804 <span type="species:ncbi:9913">calf</span>
CHO cells were cultured as monolayers in alpha-MEM (Gibco, Invitrogen Corporation) supplemented with 10% fetal calf serum (Gibco). The expression constructs empty pcD2E, pcD2E-XH, pcD2E-XHC389A, or pcD2E242-533 were transfected into EM9 cells by calcium phosphate coprecipitation and pooled populations of >50 transfectants were selected in the presence of G418 (1.5 mg/ml) for 10-14 days, creating the cell lines EM9-V, EM9-XH, EM9-XHC389A and EM9-XH242-533, respectively. The cell lines EM9-XHR399Q, EM9-XHW385D, EM9-XHLI360/361DD and the wild-type control cell lines for the latter two mutants (EM9-XH5) have been described previously (25). Spontaneously immortalized Adprt1+/+ and Adprt1-/- mouse embryonic fibroblasts (26) were cultured as monolayers in DMEM (Gibco) supplemented with 10% fetal calf serum.
###end p 11
###begin title 12
Expression constructs
###end title 12
###begin p 13
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c17">17</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c27">27</xref>
###xml 357 364 357 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 479 486 479 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
The mammalian cell expression vector pcD2E and the derivative pcD2EXH encoding C-terminally histidine-tagged XRCC1 (XRCC1-His) have been described previously (17,27). Oligonucleotide primers (Forward; 5'-CCCGAATTCGTTGACATGCACCATCACCATCACCATGGGATCCCCAAAGGGAAGAGGAAGTTG-3' and Reverse; 5'-CCCG AATTCTGCAGTCAATCAGGAGGCTCCTGGTGTTC-3') were used to amplify XRCC1242-533 using PCR. The PCR product was cloned into pCR2.1 TOPO vector (Invitrogen), confirmed by sequencing, and the XRCC1242-533 ORF subcloned into the EcoR1 site of pcD2E. Derivatives of pcD2EXH harbouring mutations within the BRCT I domain were described previously (25).
###end p 13
###begin title 14
Indirect immunofluorescence
###end title 14
###begin p 15
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 490 491 462 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 837 843 <span type="species:ncbi:9913">bovine</span>
###xml 1073 1078 <span type="species:ncbi:10090">mouse</span>
###xml 1169 1175 <span type="species:ncbi:9986">rabbit</span>
###xml 1213 1218 <span type="species:ncbi:10090">mouse</span>
###xml 1299 1305 <span type="species:ncbi:9913">bovine</span>
Cells were grown on coverslips, rinsed in PBS, and treated with either 10 mM H2O2 in PBS at room temperature for 20 min, or with 20 or 40 microg/ml MMS for 20 min at 37degreesC. Rinsed coverslips were then incubated for the indicated times in drug-free medium at 37degreesC. Coverslips were rinsed in PBS and fixed with methanol-acetone (1:1, v/v) for 10 min at 4degreesC. Fixed cells were rinsed in PBS and permeabilized for 5 min at 4degreesC in 20 mM HEPES, pH 7.4, 50 mM NaCl, 3 mM MgCl2, 300 mM sucrose, 0.5% Triton X-100. Permeabilized cells were rinsed in PBS and incubated for 20 min at 37degreesC with either anti-phospho H2AX monoclonal antibody (Upstate; clone JBW301, 1/800 dilution) or a mixture of anti-poly (ADP-ribose) monoclonal antibodies (10H; a gift from Gilbert de Murcia, 1:200 dilution in PBS supplemented with 2% bovine serum albumin, fraction V, Sigma) and anti-XRCC1 polyclonal antibodies (AHP428, Serotec, 1:200 dilution as above). After rinsing in PBS, coverslips were incubated in a mixture of either fluorescein isothiocyanate-conjugated anti-mouse IgG (DAKO) secondary antibody, or a mixture of fluorescein isothiocyanate-conjugated anti-rabbit IgG (DAKO) and TRITC-conjugated anti-mouse IgG (Sigma) secondary antibodies, at 1:200 dilution in PBS supplemented with 2% bovine serum albumin, fraction V for 20 min at 37degreesC. Nuclei were counterstained with 0.000025% 4',6'-diamidino-2-phenylindole (DAPI). Cells were analysed and photographed with a Zeiss Axioplan-2 fluorescence microscope equipped with a model RTI/CCD-1300/Y chilled charge-coupled device digital camera (Princeton, NJ) and Metamorph imaging software. Photographs were taken at 100x magnification.
###end p 15
###begin title 16
Survival curves
###end title 16
###begin p 17
###xml 118 119 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
CHO cells or MEFs (250-1000) were plated in 10-cm dishes in duplicate and exposed to the indicated concentrations of H2O2 for 10 min in PBS, or MMS for 20 min in complete medium, at 37degreesC. Cells were washed with PBS (x3) and then incubated for 7-10 days in drug-free medium to form macroscopic colonies. The surviving fraction was calculated by dividing the average number of colonies on treated plates by the average number on untreated plates. For each survival curve, data are the mean (+/-1 S.D.) of three independent experiments.
###end p 17
###begin title 18
Cell extracts and immunoblotting
###end title 18
###begin p 19
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 860 866 <span type="species:ncbi:9986">rabbit</span>
###xml 913 918 <span type="species:ncbi:10090">mouse</span>
Whole-cell extracts were prepared from frozen pellets of transfected EM9 cells (2 x 106) or MEFs (6 x 105) by resuspension in 0.2 ml of hot 2x Laemmli SDS-PAGE loading buffer [100 mM Tris-Cl (pH 6.8), 4% SDS, 0.2% Bromophenol Blue, 20% glycerol, 200 mM beta-mercaptoethanol]. High-molecular-weight DNA was sheared by passage through a narrow-gauge needle and solubilized proteins fractionated by SDS-PAGE and transferred to Nitrocellulose. Filters were rinsed with TBST (25 mM Tris-HCl, 0.5 M NaCl, 0.1% Tween-20), blocked in TBST containing 5% non-fat dried milk, and incubated for 1 h at room temperature with anti-XRCC1 polyclonal antibody (AHP428, Serotec, 1:3000 dilution in TBST supplemented with 1% milk) or anti-Actin monoclonal antibody (clone AC-40, Sigma, 1:1000 dilution). Filters were washed in TBST (3 x 15 min) and incubated with HRP-conjugated rabbit IgG (DAKO, 1:5000 dilution) or HRP-conjugated mouse IgG (DAKO, 1:5000 dilution) for 1 h at room temperature. Filters were washed in TBST (4 x 15 min) and subject to chemiluminescence detection (Amersham Biosciences).
###end p 19
###begin title 20
RESULTS
###end title 20
###begin p 21
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 209 210 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XRCC1</italic>
###xml 496 497 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 498 499 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 604 605 604 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 606 607 606 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 716 717 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 718 719 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 739 740 739 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f1">1</xref>
###xml 806 807 806 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 808 809 808 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 886 887 886 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f1">1</xref>
###xml 993 994 993 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f1">1</xref>
###xml 1113 1114 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1115 1116 1115 1116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1330 1331 1330 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f2">2</xref>
###xml 1524 1525 1512 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f2">2</xref>
###xml 333 338 <span type="species:ncbi:9606">human</span>
To examine whether XRCC1 is recruited to sites of poly (ADP-ribose) (PAR) synthesis at single-strand breaks induced by DNA oxidation, immunofluorescence experiments were conducted in CHO cells treated with H2O2. The CHO cells employed were XRCC1-mutant EM9 cells harbouring either empty pCD2E vector (EM9-V cells) or vector encoding human histidine-tagged XRCC1 (EM9-XH cells). The two cell lines were examined for co-localization of XRCC1 and PAR before and after a 20 min treatment with 10 mM H2O2. Immunostaining with anti-PAR Mabs revealed discrete nuclear foci in both EM9-V and EM9-XH cells after H2O2 treatment and these foci were absent from untreated cells, consistent with the rapid activation of PARP at H2O2-induced SSBs (Fig. 1, red). XRCC1 was similarly detected as nuclear immunofoci after H2O2 treatment, a large proportion of which co-localized with those of PAR (Fig. 1, green and 'merge'). As expected, XRCC1 signal was absent from EM9-V cells harbouring empty vector (Fig. 1 bottom right panel). Next, the kinetics at which PAR and XRCC1 foci were formed during a 2-h repair-incubation after H2O2 treatment was examined. The appearance of PAR foci in EM9-XH cells was very rapid, peaking during the 20-min incubation with drug, after which the number of foci-positive cells fell to background within 1 h (Fig. 2A, filled squares). The appearance of XRCC1 foci displayed similar kinetics, though these foci peaked a little later, after approximately10 min of repair-incubation, and persisted longer (Fig. 2A, open squares). The rapid and transient formation of PAR and XRCC1 foci is consistent with the kinetics of the rapid SSBR process.
###end p 21
###begin p 22
###xml 390 395 390 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 516 521 516 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f2">2</xref>
###xml 669 674 669 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 697 698 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 699 700 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 877 878 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f2">2</xref>
###xml 967 972 967 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 1141 1142 1141 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f3">3</xref>
The observation that XRCC1 foci appeared with slightly delayed kinetics when compared to those of PAR is consistent with the hypothesis that PARP-1 binds DNA strand breaks and is activated, and then recruits XRCC1 to those breaks to facilitate repair. To test whether the formation of XRCC1 foci may reflect the recruitment of XRCC1 by PAR, we examined the formation of XRCC1 foci in EM9-XHC389A cells expressing XRCC1 with a mutated BRCT I domain. The kinetics with which PAR foci appeared and disappeared in EM9-XHC389A cells was similar to that in EM9-XH cells (Fig. 2A, compare filled squares and filled circles). In contrast, the appearance of XRCC1 foci in EM9-XHC389A cells in response to H2O2 was reduced in comparison to EM9-XH cells, as measured by the number of foci-positive cells (cells with >6 foci) observed at different times during the repair incubation (Fig. 2A, compare open circles and open squares). The reduced appearance of XRCC1 foci in EM9-XHC389A cells was not explained by lower levels of XRCC1 protein because this mutant cell line exhibited slightly higher levels of XRCC1 than did EM9-XH cells (see later, Fig. 3C).
###end p 22
###begin p 23
###xml 6 11 6 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f2">2</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f3">3</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c22">22</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c28">28</xref>
###xml 862 873 862 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LI360/361DD</sup>
###xml 884 889 884 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W385D</sup>
###xml 903 904 903 904 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 905 906 905 906 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 913 914 913 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f3">3</xref>
###xml 924 929 924 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W385D</sup>
###xml 1036 1037 1024 1025 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1038 1039 1026 1027 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1308 1309 1296 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f3">3</xref>
###xml 1434 1436 1422 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
###xml 1170 1175 <span type="species:ncbi:9606">human</span>
EM9-XHC389A cells were only slightly more sensitive to MMS and H2O2 than were EM9-XH cells (Fig. 2B). This small effect on survival is in contrast to two other mutations in BRCT I domain that we have examined previously, including one mutation located only four amino acids from C389, which entirely prevents the ability of XRCC1 to maintain cell survival after MMS (25). We therefore examined the impact of these additional BRCT I mutations on assembly of XRCC1 foci. One of the mutations is a double substitution of Leu360/Ileu361 with two Asp residues and the second is a single substitution of Trp385 with Asp (Fig. 3A). Similar to C389, Trp385 lies within the PAR binding motif (22), and mutation of Leu360 has previously been reported to prevent the interaction between XRCC1 and PARP-1 (28). The appearance of XRCC1 nuclear foci was reduced in both EM9-XHLI360/361DD and EM9-XHW385D cells after H2O2 (Fig. 3B). EM9-XHW385D cells exhibited the greatest reduction, with approximately10-fold fewer XRCC1 foci observed 10 min after H2O2 treatment than was observed in wild-type EM9-XH5 cells. In contrast to the LI360/361DD and W385D mutations, a naturally occurring human polymorphism (XRCC1 399Q) located at the very end of the BRCT I domain did not measurably affect the appearance of XRCC1 foci (Fig. 3B). This is consistent with our previous observation that this polymorphism does not measurably impact on SSBR in CHO cells (25).
###end p 23
###begin p 24
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
###xml 186 206 186 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis thaliana</italic>
###xml 292 302 292 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A.thaliana</italic>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f3">3</xref>
###xml 505 512 505 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 579 580 579 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 581 582 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 646 647 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 648 649 648 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f3">3</xref>
###xml 905 912 905 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 971 972 971 972 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 973 974 973 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 988 989 988 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f2">2</xref>
###xml 186 206 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 292 302 <span type="species:ncbi:3702">A.thaliana</span>
###xml 453 458 <span type="species:ncbi:9606">human</span>
The BRCT I domain and the linker located between this domain and the C-terminal BRCT II domain are the most evolutionary conserved regions of XRCC1 (25). Indeed, a putative homologue in Arabidopsis thaliana is comprised of just these domains. We therefore expressed a human equivalent of the A.thaliana XRCC1, encoding residues 242-533 (see Fig. 3A and C), to examine whether these two evolutionary conserved domains are sufficient to allow assembly of human XRCC1 into nuclear foci. Interestingly, EM9-XH242-533 cells exhibited high levels of XRCC1 foci even in the absence of H2O2, though an increase in foci-positive cells was observed after H2O2 (Fig. 3B). The BRCT I domain and the linker region located downstream of this domain are thus sufficient for assembly of XRCC1 in subnuclear foci, though other domains of XRCC1 may be important to regulate this process. Perhaps consistent with this, XRCC1242-533 failed to correct the sensitivity of EM9 cells to either H2O2 or MMS (Fig. 2B, open squares).
###end p 24
###begin p 25
###xml 242 249 242 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adprt-1</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c26">26</xref>
###xml 399 404 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 420 421 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 422 423 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 452 455 452 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 469 470 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 479 484 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 484 487 484 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 484 487 484 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 500 501 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 502 503 502 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f4">4</xref>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 556 559 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 556 559 556 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 572 573 572 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 574 575 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 623 624 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f4">4</xref>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 766 769 766 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 766 769 766 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 783 784 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 785 786 785 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 910 911 910 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 912 913 912 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1062 1063 1062 1063 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1064 1065 1064 1065 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1069 1074 1069 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 1074 1077 1074 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 1074 1077 1074 1077 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 1090 1091 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f5">5</xref>
###xml 1248 1249 1248 1249 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1250 1251 1250 1251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1453 1458 1453 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 1458 1461 1458 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 1458 1461 1458 1461 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 1466 1471 1466 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 1471 1474 1471 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 1471 1474 1471 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 1513 1514 1513 1514 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1515 1516 1515 1516 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1533 1534 1533 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f5">5</xref>
If PARP-1 activity is required to recruit XRCC1 to sites of SSBs, then XRCC1 should fail to assemble into foci in cells lacking PARP-1. We therefore examined the formation of Xrcc1 foci in MEFs harbouring targeted disruption of exon 1 of the Adprt-1 gene (from here on termed Parp1 for clarity) that encodes Parp-1 (26). As expected, immunostaining with anti-PAR antibodies revealed nuclear foci in Parp1+/+ MEFs after H2O2, but few or no foci in Parp1+/+ MEFs before H2O2 or in Parp1-/- MEFs after H2O2 (Fig. 4, red). Similarly, Xrcc1 foci formed in Parp1+/+ MEFs after H2O2, and many of these co-localized with PAR (Fig. 4, green). Typically, we observed between 10 and 30 Xrcc1/PAR foci per cell. Strikingly, however, Xrcc1 nuclear foci were not detected in Parp1-/- cells after H2O2, demonstrating that PARP-1 is required for the appearance of Xrcc1 foci after exposure to this drug. Although the dose of H2O2 employed in these experiments (10 mM) is lethal, similar numbers of Xrcc1 foci-positive cells were observed at lower, more physiological, doses of H2O2 in Parp1+/+ cells (Fig. 5A and B). Once again, between 10 and 30 foci were typically observed per cell, and these foci were both similar in appearance to those observed after 10 mM H2O2 and were similarly co-localized with sites of PAR (data not shown). The absence of Xrcc1 foci did not reflect an impact of PARP-1 on Xrcc1 protein levels because Xrcc1 was present at similar levels in Parp1+/+ and Parp1-/- cell extracts, both before and after H2O2 treatment (Fig. 5C).
###end p 25
###begin p 26
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 166 169 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 166 169 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 286 289 286 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 286 289 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f6">6</xref>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 372 375 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 372 375 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 508 511 508 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 508 511 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 698 701 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 698 701 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 706 711 706 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 711 714 711 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 711 714 711 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 747 748 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 749 750 749 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f6">6</xref>
Similar results were observed when the response of Parp1+/+ and Parp1-/- cells to the alkylating agent methyl methanesulphonate (MMS) was examined. Whereas most Parp1+/+ cells exhibited Xrcc1 and PAR foci that co-localized extensively after exposure to physiological doses of MMS, Parp1-/- cells did not (Fig. 6A and B). Finally, to rule out the possibility that the Parp1-/- MEFs employed here were unable to mount any response to DNA damage under the conditions employed, we compared these cells with Parp1+/+ MEFs for the appearance of phospho H2AX foci, an early event triggered in response to DNA strand breaks. In contrast to XRCC1 foci, the appearance of H2AX foci was observed in both Parp1+/+ and Parp1-/- cells, after exposure to 10 mM H2O2 (Fig. 6C).
###end p 26
###begin title 27
DISCUSSION
###end title 27
###begin p 28
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c21">21</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c29">29</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c30">30</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c13">13</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c19">19</xref>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c2">2</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c31">31</xref>
###xml 749 755 749 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp-1</italic>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c22">22</xref>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
The phenotype of cells in which PARP-1 is inhibited or absent is consistent with a role in DNA repair (21,29,30), but the nature of this role is unclear. A direct physical link between PARP-1 and the DNA strand break repair machinery emerged with the discovery that PARP-1 interacts with the BRCT I domain of XRCC1 (13,19). XRCC1 appears to operate as a molecular scaffold protein that interacts with and stimulates enzymatic components of single strand break repair (2,31). In this study, we have shown that PARP-1 is required for the rapid appearance of XRCC1 nuclear foci after oxidative damage and that these foci co-localize with sites of PAR synthesis. PAR synthesis was the product of PARP-1 activity because it was absent from MEFs in which Parp-1 was disrupted. The appearance of XRCC1 foci was dependent upon the central BRCT I domain in this polypeptide, which has been shown previously to interact with PAR polymer and to be critical for the role of XRCC1 in SSBR and for cell survival (22,25).
###end p 28
###begin p 29
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c2">2</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c31">31</xref>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c32">32</xref>
What are the nature of the breaks at which PARP-1 and XRCC1 foci assemble? Given the extensive involvement of XRCC1 in SSBR (2,31), it seems likely that SSBs are responsible for the foci observed after H2O2, though an involvement of DSBs is possible (32). It is likely that the XRCC1/PAR foci reported here are physiologically relevant sites of DNA strand break repair because they rapidly disappeared during a repair incubation in drug-free medium. These foci could reflect the steady state number of DNA strand breaks undergoing repair at the time of fixation, or alternatively could reflect a discrete number of 'repair factories' into which DNA strand breaks are recruited.
###end p 29
###begin p 30
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c33">33</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c33">33</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c34">34</xref>
XRCC1 is required for at least two types of SSBR process, a rapid pathway that occurs throughout the cell cycle and a second pathway that is specific for S/G2 phase (33). In addition, there exists at least one additional SSBR pathway that is XRCC1 independent. Of the two identified XRCC1-dependent processes, the S/G2 pathway appears to be the most important for cell survival. Indeed, the S/G2 process can largely compensate for absence of the rapid pathway, possibly by removing unrepaired SSBs when they are encountered by the replication fork (33,34). It is unclear whether the XRCC1/PAR foci observed here are associated with one or both of these processes, though the rapid appearance of PAR foci and XRCC1 foci correlates best with the rapid pathway.
###end p 30
###begin p 31
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c35">35</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c37">37</xref>
###xml 487 495 487 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c19">19</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c22">22</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c24">24</xref>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c22">22</xref>
###xml 1589 1591 1577 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
The requirement for PARP-1 for assembly of XRCC1 foci could be direct, via the ability of these polypeptides to interact. Alternatively, it could reflect an indirect impact of PARP-1 on the expression of other repair genes or on chromatin architecture (35-37). However, we favour the model that PARP-1 directly recruits XRCC1 via the binding of PAR polymer to XRCC1, for several reasons. First, XRCC1 interacts preferentially with ribosylated PARP-1 and XRCC1 binds purified PAR polymer in vitro (19,22-24). This strongly suggests that PARP-1 recruits XRCC1 by physical interaction once PAR synthesis is triggered at a DNA strand break. Second, the interaction of XRCC1 with PAR polymer occurs via a motif within the BRCT I domain, mutations within which reduced the formation of XRCC1 foci after oxidative DNA damage. Also, a truncated XRCC1 polypeptide encoding just the BRCT I domain and the linker domain between BRCT I and BRCT II was able to form XRCC1 foci, albeit in an apparently deregulated fashion that may not be responsive to oxidative DNA damage. The difference observed in the impact of the three mutations on foci formation may be due to leakiness, since there is a high degree of redundancy amongst PAR-binding motifs (22). The LI360/361DD and W385D mutations had the greatest effect on foci formation, reducing their appearance by approximately3- and 10-fold, respectively. These mutations appear to impact specifically on functions of the BRCT I domain because we have shown previously that they do not prevent protein-protein interactions mediated by flanking domains (25). Together, these data best support a model in which PARP-1 mediates the assembly of XRCC1 foci after oxidative DNA damage by direct interaction of the XRCC1 BRCT I domain with PAR polymer, thereby recruiting XRCC1 to sites of DNA strand breakage.
###end p 31
###begin p 32
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
A requirement for PARP-1 for recruiting XRCC1 to strand breaks during DNA repair reactions in vitro has not been reported. This may reflect that the active recruitment of XRCC1 to breaks is not required for repair in simple cell-free reactions, because the high concentration of DNA breaks and soluble repair factors in such experiments prevent the detection of DNA breaks from being a rate limiting step. However, active recruitment of XRCC1 and its protein partners may be important to accelerate the detection and repair of SSBs within the context of the nuclear genome, in which DNA breaks are relatively rare and distributed amongst many kilobases of undamaged DNA. It is also possible that the recruitment of XRCC1 is important for repair of chromatin, rather than naked plasmid DNA or oligonucleotide duplex.
###end p 32
###begin p 33
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c31">31</xref>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 281 284 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 544 546 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c38">38</xref>
###xml 547 549 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c40">40</xref>
###xml 649 651 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c13">13</xref>
###xml 652 654 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c14">14</xref>
###xml 655 657 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c31">31</xref>
###xml 878 880 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c23">23</xref>
###xml 881 883 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c35">35</xref>
###xml 884 886 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c41">41</xref>
###xml 887 889 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c42">42</xref>
We have suggested that PARP-1 may primarily be required to recruit XRCC1 to direct DNA breaks, which are 'un-scheduled' and require rapid detection (31). It is feasible that PARP-1 also recruits XRCC1 to SSBs arising during BER, since both PAR and XRCC1 foci were absent from Parp1-/- MEFs after exposure to the alkylating agent, MMS. However, it is more difficult to envisage a need for PARP to 'detect' breaks during early stages of BER, since current models suggest that breaks created by APE1 can be passed directly to DNA polymerase beta (38-40) which in turn may itself then recruit XRCC1/DNA ligase IIIalpha for the completion of DNA repair (13,14,31). Perhaps PAR synthesis after base damage reflects binding by PARP-1 to SSBs at a later stage of BER, since PARP-1 may influence the choice of whether short patch or long patch repair is employed during DNA gap filling (23,35,41,42). Alternatively, PAR synthesis after base damage could reflect a fraction of abasic sites that become 'uncoupled' from APE1 after cleavage or that are cleaved by an AP lyase activity, either of which might be expected to result in 'exposed' SSBs that require rapid detection by PARP-1.
###end p 33
###begin p 34
In summary, these data show that PARP-1 is required for assembly or stability of XRCC1 nuclear foci after oxidative DNA damage, consistent with a model in which poly (ADP-ribose) synthesis serves to recruit XRCC1 to sites of DNA strand breakage.
###end p 34
###begin title 35
Figures and Tables
###end title 35
###begin p 36
###xml 208 209 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 238 239 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 131 136 <span type="species:ncbi:9606">human</span>
 Co-localization of XRCC1 foci at sites of poly (ADP-ribose) synthesis after oxidative DNA damage. EM9 CHO cells expressing either human XRCC1 (EM9-XH) or harbouring empty vector (EM9-V) were mock-treated (-H2O2) or treated with 10 mM H2O2 for 20 min and then incubated in drug-free medium for 10 min. Untreated and treated cells were then fixed with methanol/acetone and immunostained with anti-poly (ADP-ribose) ('PAR') monoclonal antibody 10H and anti-XRCC1 polyclonal antibody (AHP428, Serotec) for analysis by indirect immunofluorescence. Representative images (x100 magnification) were photographed and coloured using an RTI/CCD-1300/Y digital camera and Metamorph software.
###end p 36
###begin p 37
###xml 104 109 104 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 112 113 112 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 147 152 147 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 224 225 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f1">1</xref>
###xml 794 795 794 795 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 949 950 949 950 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 951 952 951 952 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 84 89 <span type="species:ncbi:9606">human</span>
 Temporal assembly of PAR foci and XRCC1 foci in EM9 CHO cells expressing wild-type human XRCC1 or XRCC1C389A. (A) EM9-XH cells (squares) or EM9-XHC389A cells (circles) were mock-treated ('no damage') or treated with 10 mM H2O2 for 20 min and then incubated for 0, 10, 30, 60 or 120 min as indicated ('R0-R120') in drug-free medium to allow time for repair. Cells were then fixed and immunostained with anti-PAR antibodies (solid lines) and anti-XRCC1 antibodies (dotted lines) as described for Figure 1. For each time point, 100 cells were scored for the presence of six or more foci per cell. Data points are the mean of two or three experiments and error bars represent the data range or 1 S.D. from the mean (R10), respectively. Where not visible, error bars are smaller than the symbols. (B) 250 cells of the indicated cell lines were plated in 10 cm dishes in duplicate and either mock-treated or treated with the indicated concentrations of H2O2 for 10 min or MMS for 1 h. Cells were then rinsed in PBS and incubated in drug-free medium for 7-10 days to allow formation of macroscopic colonies. Survival was calculated by dividing the average number of colonies on treated plates by the average number on untreated plates. Data are the mean of three independent experiments for each drug and error bars represent +/-1 S.D. Where not visible, error bars are smaller than the symbols.
###end p 37
###begin p 38
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 146 153 146 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 358 359 358 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 438 439 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 440 441 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 525 526 525 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 527 528 527 528 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f1">1</xref>
###xml 938 949 938 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LI360/361DD</sup>
###xml 960 965 960 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W385D</sup>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
###xml 1138 1145 1138 1145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 1156 1161 1156 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R399Q</sup>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg761c25">25</xref>
###xml 1169 1170 1169 1170 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1217 1224 1217 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">242&#8211;533</sup>
###xml 1235 1240 1235 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C389A</sup>
###xml 1021 1026 <span type="species:ncbi:9606">human</span>
 The BRCT I domain is required for appearance of XRCC1 nuclear foci after oxidative DNA damage. (A) Schematic of full-length XRCC1 (top) and XRCC1242-533 (bottom) depicting the proposed PAR- binding motif (dotted box) located within BRCT I domain. The position of the nuclear localization signal (NLS) and of the mutations employed in this study are shown. (B) Mutation of the BRCT I domain inhibits assembly of XRCC1 nuclear foci after H2O2 treatment. The indicated cell lines were mock-treated ('-') or treated ('+') with H2O2 for 20 min, incubated in drug-free medium for 10 min, and then processed for anti-XRCC1 immunofluorescence as described for Figure 1. 100 cells from each cell line were scored for the presence or absence of six or more foci. Each data point represents the mean of two independent experiments and error bars reflect the data range. EM9-XH5 is a single transfectant clone and is the wild-type control for EM9-XHLI360/361DD and EM9-XHW385D, with which it expresses similar levels of recombinant human XRCC1 (25). EM9-XH is a pooled population of more than 50 transfectants and is the control cell line for EM9-XH242-533 and EM9-XHR399Q (25). (C) XRCC1 protein levels in EM9-V, EM9-XH, EM9-XH242-533 and EM9-XHC389A cells. Protein extracts from the indicated cell lines were fractionated by SDS-PAGE, transferred to nitrocellulose and immunoblotted with anti-XRCC1 polyclonal antibody.
###end p 38
###begin p 39
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 169 170 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 171 172 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
 PARP-1 is required for appearance of XRCC1 nuclear foci at sites of oxidative DNA damage. Parp1+/+ or Parp1-/- MEFs were mock-treated or treated for 20 min with 10 mM H2O2 and then incubated in drug-free medium for 10 min. Cells were then fixed in methanol/acetone and processed for indirect immunofluorescence using anti-PAR monoclonal antibody and anti-XRCC1 polyclonal antibody and counterstained with DAPI. Representative cells are shown (x100 magnification).
###end p 39
###begin p 40
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 55 56 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 88 89 88 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 167 168 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 169 170 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f4">4</xref>
###xml 580 581 580 581 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 615 618 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 622 627 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 627 630 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 627 630 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 682 683 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 684 685 684 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f2">2</xref>
###xml 729 730 729 730 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 771 772 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 773 774 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 783 788 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 788 791 788 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 788 791 788 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 795 800 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 800 803 800 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 800 803 800 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
 XRCC1 protein levels, nuclear foci and survival to H2O2 in Parp1+/+ or Parp1-/- MEFs. (A) Parp1+/+ MEFs were treated for 20 min with the indicated concentrations of H2O2 and then incubated in drug-free medium for 10 min. Cells were immunostained for Xrcc1 and PAR as described in Figure 4 and the fraction of cells with >6 Xrcc1 foci was determined. The absence of visible bars for untreated cells indicates the absence of detectable foci-positive cells. Data are the mean of duplicate samples from a single experiment, and the data range for each duplicate was less than five. (B) The clonogenic survival of Parp1+/+ or Parp1-/- MEFs treated with the indicated concentrations of H2O2 was determined as described in Figure 2B. (C) Protein extracts from mock-treated or H2O2-treated Parp1+/+ or Parp1-/- MEFs were fractionated by SDS-PAGE, transferred to nitrocellulose and immunoblotted with anti-XRCC1 polyclonal, or anti-actin monoclonal, antibody.
###end p 40
###begin p 41
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f4">4</xref>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 646 647 646 647 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 676 681 676 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 681 684 681 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 681 684 681 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 693 696 693 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 693 696 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg761f2">2</xref>
###xml 862 863 862 863 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 865 870 865 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 870 873 870 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+</italic>
###xml 870 873 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>+/+</italic></sup>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parp1</italic>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</italic>
###xml 882 885 882 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8211;/&#8211;</italic></sup>
###xml 943 944 943 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 945 946 945 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
 XRCC1 and H2AX nuclear foci in Parp1+/+ and Parp1-/- MEFs following exposure to MMS and H2O2. (A) Parp1+/+ ('+/+') and Parp1-/- ('-/-') MEFs were treated for 20 min with the indicated concentrations of MMS and then incubated in drug-free medium for 10 min. Cells were immunostained for Xrcc1 and PAR as described in Figure 4 and the fraction of cells with >6 Xrcc1 foci was determined. The absence of visible bars for untreated cells and for treated Parp1-/- MEFs indicates the absence of detectable foci-positive cells. Data are the mean of duplicate samples from a single experiment, and the data range for each duplicate was less than five. (B) The clonogenic survival of Parp1+/+ or Parp1-/- MEFs treated with the indicated concentrations of MMS for 1 h was determined as described in Figure 2B. Where not visible, error bars are smaller than the symbols. (C) Parp1+/+ or Parp1-/- MEFs were mock-treated or treated for 20 min with 10 mM H2O2 as indicated and then incubated in drug-free medium for 10 min. Cells were then fixed in methanol/acetone and processed for indirect immunofluorescence using anti-phospho H2AX monoclonal antibody (Upstate; clone JBW301) and counterstained with DAPI. Representative cells are shown (x100 magnification).
###end p 41
###begin title 42
ACKNOWLEDGEMENTS
###end title 42
###begin p 43
S.E.K. is funded by an MRC Programme Grant (G0001259) to K.W.C. We thank Gilbert de Murcia for the gift of anti-PAR antibodies.
###end p 43
###begin title 44
REFERENCES
###end title 44

